Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Proteomics International Laboratories Ltd. (AU:PIQ)
ASX:PIQ
RESEARCH TOOLSreports
Holding AU:PIQ?
Track your performance easily
PIQ Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.55 - AU$1.40
Previous CloseAU$0.57
Volume71.38K
Average Volume (3M)217.75K
Market Cap
AU$75.73M
Enterprise ValueAU$71.91M
Total Cash (Recent Filing)AU$2.11M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta0.93
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares OutstandingN/A
10 Day Avg. Volume593,150
30 Day Avg. Volume217,754
Standard Deviation0.19
R-Squared0.02
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)57.03
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.50Price Target Upside-24.81% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering1
Proteomics International Laboratories Ltd. News
PremiumCompany Announcements
Proteomics International Appoints New Director
PremiumCompany Announcements
Proteomics International Presents Future of Diagnostics
PremiumCompany Announcements
Proteomics International Welcomes New Board Expertise
PremiumCompany Announcements
Proteomics International Advances PromarkerD in US
PremiumCompany Announcements
Proteomics Intl Ends 50K Performance Rights
PremiumCompany Announcements
Proteomics International Expands Diabetes Care
PremiumCompany Announcements
Proteomics International Advances Healthcare InnovationPremiumCompany Announcements
Proteomics International Embraces Tailored GovernanceOptions Prices
Currently, No data available
---
Ownership Overview
20.25% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
79.75% Public Companies and
Individual Investors
PIQ FAQ
What was Proteomics International Laboratories Ltd.’s price range in the past 12 months?
Proteomics International Laboratories Ltd. lowest share price was AU$0.55 and its highest was AU$1.40 in the past 12 months.
What is Proteomics International Laboratories Ltd.’s market cap?
Currently, no data Available
When is Proteomics International Laboratories Ltd.’s upcoming earnings report date?
Proteomics International Laboratories Ltd.’s upcoming earnings report date is Feb 26, 2025 which is in 159 days.
How were Proteomics International Laboratories Ltd.’s earnings last quarter?
Proteomics International Laboratories Ltd. released its earnings results on Aug 22, 2024. The company reported -AU$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.02.
Is Proteomics International Laboratories Ltd. overvalued?
According to Wall Street analysts Proteomics International Laboratories Ltd.’s price is currently Overvalued.
Does Proteomics International Laboratories Ltd. pay dividends?
Proteomics International Laboratories Ltd. does not currently pay dividends.
What is Proteomics International Laboratories Ltd.’s EPS estimate?
Proteomics International Laboratories Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Proteomics International Laboratories Ltd. have?
Proteomics International Laboratories Ltd. has 131,002,720 shares outstanding.
What happened to Proteomics International Laboratories Ltd.’s price movement after its last earnings report?
Proteomics International Laboratories Ltd. reported an EPS of -AU$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.381%.
Which hedge fund is a major shareholder of Proteomics International Laboratories Ltd.?
Currently, no hedge funds are holding shares in AU:PIQ
---
Proteomics International Laboratories Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
AU$0.50 (-24.81% Downside)
AU$0.50 (-24.81% Downside)
Blogger Sentiment
Bullish
AU:PIQ Sentiment 100%
Sector Average 71%
Sector Average 71%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.22%
12-Months-Change
Fundamentals
Return on Equity
-71.67%
Trailing 12-Months
Asset Growth
7.94%
Trailing 12-Months
Company Description
Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial scale study of the structure and function of proteins. Its operations are divided into PromarkerD that targets the global diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.
---
PIQ Stock 12 Month Forecast
Average Price Target
AU$0.50
▼(-24.81% Downside)
Technical Analysis
Best Analysts Covering PIQ
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+10.30%
downgraded a sell rating 8 days ago
Copying Iain Wilkie's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +10.30% per trade.
---